Outset Medical
About: Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
Employees: 480
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
2% more call options, than puts
Call options by funds: $57K | Put options by funds: $56K
35% less funds holding
Funds holding: 122 [Q2] → 79 (-43) [Q3]
57.21% less ownership
Funds ownership: 107.26% [Q2] → 50.05% (-57.21%) [Q3]
59% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 37
84% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 49
92% less capital invested
Capital invested by funds: $214M [Q2] → $17.6M (-$196M) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$3
272%
upside
Avg. target
$3
272%
upside
High target
$3
272%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
RBC Capital Shagun Singh 52% 1-year accuracy 36 / 69 met price target | 272%upside $3 | Sector Perform Reiterated | 7 Jan 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
2 weeks ago
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt
Neutral
GlobeNewsWire
1 month ago
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ: OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company.
Neutral
GlobeNewsWire
2 months ago
Outset Medical to Present at the 2024 Stifel Healthcare Conference
SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.
Neutral
Seeking Alpha
2 months ago
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript
Outset Medical Inc. (NASDAQ:OM ) Q3 2024 Results Conference Call November 6, 2024 5:00 PM ET Company Participants James Mazzola - Head of Investor Relations Leslie Trigg - President, CEO & Chairman Nabeel Ahmed - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Avi Kohn RBC - Capital Markets Suraj Kalia - Oppenheimer & Co Marie Thibault - BTIG Josh Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Outset Medical Conference Call.
Negative
Zacks Investment Research
2 months ago
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.71 per share a year ago.
Neutral
GlobeNewsWire
2 months ago
Outset Medical Reports Third Quarter 2024 Financial Results
SAN JOSE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2024.
Neutral
Accesswire
2 months ago
Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM)
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109746&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
2 months ago
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109727&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
2 months ago
Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - OM
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109608&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
2 months ago
FINAL OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Outset Medical, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between September 15, 2020, and August 7, 2024, inclusive (the "Class Period").
Charts implemented using Lightweight Charts™